Although the key role of the gut microbiota in stimulating IDO1 activity has been demonstrated in both GF and Abx-treated mouse models44, there has been very little focus on the modulatory influences on host Trp catabolism through the Kyn pathway exerted by specific commensal bacteria and microbial metabolites in IBD. This evidence concerns the gene IDO1 and inflammatory bowel disease.